Oct 1, 2018 |
$677,538
|
LYRICA
|
Consulting
|
PFIZER INC. |
|
Sep 7, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Nov 7, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Oct 19, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Mar 21, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Aug 17, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jan 12, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Dec 14, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Apr 11, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jul 13, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
May 9, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jun 6, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Feb 23, 2018 |
$250,000
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Aug 9, 2018 |
$162,500
|
ARYMO ER
|
Consulting
|
EGALET US INC |
|
Jun 14, 2018 |
$162,500
|
ARYMO ER
|
Consulting
|
EGALET US INC |
|
Oct 29, 2018 |
$137,183
|
LYRICA
|
Consulting
|
PFIZER INC. |
|
Sep 19, 2018 |
$110,000
|
ARYMO ER
|
Consulting
|
EGALET US INC |
|
Dec 31, 2018 |
$105,592
|
No Listed Product
|
Grant
|
GILEAD SCIENCES INC |
|
Dec 31, 2018 |
$94,845
|
BUPRENORPHINE
BUPRENORPHINE & NALOXONE
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Jun 30, 2018 |
$92,321
|
BUPRENORPHINE
BUPRENORPHINE & NALOXONE
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Sep 30, 2018 |
$90,642
|
BUPRENORPHINE
BUPRENORPHINE & NALOXONE
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Apr 11, 2018 |
$81,926
|
BUPRENORPHINE
BUPRENORPHINE & NALOXONE
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Mar 9, 2018 |
$75,000
|
ARYMO ER
|
Consulting
|
EGALET US INC |
|
Mar 2, 2018 |
$75,000
|
ARYMO ER
|
Consulting
|
EGALET US INC |
|
Jun 14, 2018 |
$57,363
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Oct 17, 2018 |
$54,282
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Nov 14, 2018 |
$52,810
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Mar 14, 2018 |
$50,579
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Apr 18, 2018 |
$50,441
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Dec 12, 2018 |
$49,886
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
May 16, 2018 |
$49,612
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Sep 19, 2018 |
$49,581
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Mar 21, 2018 |
$49,486
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Jan 24, 2018 |
$49,348
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Jun 6, 2018 |
$48,918
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Sep 5, 2018 |
$48,257
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Aug 8, 2018 |
$35,675
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Jun 18, 2018 |
$32,500
|
No Listed Product
|
Grant
|
SYNTHES GMBH |
|
Apr 10, 2018 |
$30,000
|
No Listed Product
|
Grant
|
SYNTHES GMBH |
|
Jun 14, 2018 |
$24,067
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Oct 15, 2018 |
$20,660
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Aug 8, 2018 |
$18,863
|
CABOZANTINIB
|
Promotional Speaking/Other
|
EXELIXIS INC. |
|
Oct 19, 2018 |
$16,500
|
HYSINGLA ER
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jul 13, 2018 |
$16,500
|
HYSINGLA ER
|
Consulting
|
PURDUE PHARMA L.P. |
|
Apr 11, 2018 |
$16,500
|
HYSINGLA ER
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jan 10, 2018 |
$16,500
|
HYSINGLA ER
|
Consulting
|
PURDUE PHARMA L.P. |
|
May 31, 2018 |
$16,146
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
Mar 1, 2018 |
$16,111
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
Feb 9, 2018 |
$13,027
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
May 23, 2018 |
$12,496
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Oct 15, 2018 |
$11,769
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Jun 14, 2018 |
$11,186
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Aug 17, 2018 |
$11,145
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jul 18, 2018 |
$10,349
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Feb 21, 2018 |
$9,967
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jun 14, 2018 |
$9,744
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Oct 15, 2018 |
$9,427
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Mar 23, 2018 |
$9,296
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jun 13, 2018 |
$9,076
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Sep 21, 2018 |
$8,425
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Oct 17, 2018 |
$8,420
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Oct 15, 2018 |
$8,365
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Nov 21, 2018 |
$8,222
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Dec 19, 2018 |
$7,497
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Apr 20, 2018 |
$7,248
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jan 24, 2018 |
$7,210
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jan 4, 2018 |
$6,950
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
Feb 9, 2018 |
$5,189
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
Jan 4, 2018 |
$5,032
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
Aug 30, 2018 |
$4,346
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
Sep 19, 2018 |
$4,000
|
ARYMO ER
|
Consulting
|
EGALET US INC |
|
May 30, 2018 |
$2,500
|
No Listed Product
|
Education
|
ACELL, INC. |
|
Jan 31, 2018 |
$1,575
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jun 1, 2018 |
$1,500
|
XARELTO
|
Space rental or facility fees(teaching hospital only)
|
JANSSEN PHARMACEUTICALS, INC |
|
May 8, 2018 |
$1,500
|
No Listed Product
|
Space rental or facility fees(teaching hospital only)
|
KLS-MARTIN L.P. |
|
Jun 7, 2018 |
$1,500
|
No Listed Product
|
Grant
|
ZIMMER BIOMET HOLDINGS, INC. |
|
May 28, 2018 |
$1,500
|
ACTIVASE
CATHFLO ACTIVASE
TNKASE
|
Space rental or facility fees(teaching hospital only)
|
GENENTECH USA, INC. |
|
Nov 28, 2018 |
$1,400
|
No Listed Product
|
Consulting
|
PURDUE PHARMA L.P. |
|
Jul 3, 2018 |
$1,393
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Mar 8, 2018 |
$1,357
|
No Listed Product
|
Education
|
ACELL, INC. |
|
Dec 15, 2018 |
$1,254
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Dec 15, 2018 |
$1,254
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Nov 15, 2018 |
$1,116
|
BUPRENORPHINE HYDROCHLORIDE
|
Promotional Speaking/Other
|
MYLAN PHARMACEUTICALS INC. |
|
Apr 27, 2018 |
$780
|
No Listed Product
|
Grant
|
MEDICAL DEVICE BUSINESS SERVICES, INC. |
|
Dec 15, 2018 |
$714
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Dec 15, 2018 |
$714
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Jul 3, 2018 |
$651
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jul 3, 2018 |
$643
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Jul 12, 2018 |
$627
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Jul 3, 2018 |
$627
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Jul 12, 2018 |
$627
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Jul 3, 2018 |
$627
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Jul 3, 2018 |
$564
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Dec 15, 2018 |
$508
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Dec 15, 2018 |
$508
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
May 10, 2018 |
$500
|
HOFFMANN
|
Space rental or facility fees(teaching hospital only)
|
STRYKER CORPORATION |
|
Nov 8, 2018 |
$500
|
ASNIS
GAMMA
OMEGA
T2
|
Space rental or facility fees(teaching hospital only)
|
STRYKER CORPORATION |
|
Apr 18, 2018 |
$500
|
No Listed Product
|
Charitable Contribution
|
OWENS & MINOR DISTRIBUTION, INC. |
|
Oct 15, 2018 |
$494
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Jun 14, 2018 |
$486
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Oct 15, 2018 |
$417
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jun 25, 2018 |
$350
|
No Listed Product
|
Space rental or facility fees(teaching hospital only)
|
ZOLL MEDICAL CORPORATION |
|
Sep 4, 2018 |
$350
|
No Listed Product
|
Space rental or facility fees(teaching hospital only)
|
ZOLL MEDICAL CORPORATION |
|
Apr 16, 2018 |
$350
|
No Listed Product
|
Consulting
|
ZOLL MEDICAL CORPORATION |
|
Jun 14, 2018 |
$341
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Jul 2, 2018 |
$309
|
No Listed Product
|
Food and Beverage
|
MERGE HEALTHCARE INCORPORATED |
|
Jul 25, 2018 |
$303
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Sep 15, 2018 |
$296
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Jul 3, 2018 |
$293
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jul 12, 2018 |
$293
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jul 12, 2018 |
$293
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jul 3, 2018 |
$293
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jul 3, 2018 |
$290
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Jul 3, 2018 |
$290
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Jul 12, 2018 |
$290
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Jul 12, 2018 |
$290
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Oct 15, 2018 |
$281
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Jul 3, 2018 |
$254
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Jul 3, 2018 |
$254
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Jul 12, 2018 |
$254
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Jul 12, 2018 |
$254
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Jun 14, 2018 |
$230
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Oct 15, 2018 |
$225
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jan 10, 2018 |
$210
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Oct 15, 2018 |
$200
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Oct 15, 2018 |
$191
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Jul 11, 2018 |
$189
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Oct 10, 2018 |
$153
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Jul 25, 2018 |
$142
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jul 25, 2018 |
$140
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Sep 15, 2018 |
$137
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Sep 15, 2018 |
$134
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Jul 25, 2018 |
$123
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Sep 15, 2018 |
$120
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Oct 15, 2018 |
$108
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Jul 11, 2018 |
$85
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Jan 10, 2018 |
$72
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Oct 15, 2018 |
$62
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Oct 10, 2018 |
$51
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Oct 15, 2018 |
$49
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Aug 16, 2018 |
$48
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Oct 15, 2018 |
$44
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Jul 3, 2018 |
$28
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Dec 5, 2018 |
$25
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Dec 5, 2018 |
$25
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Oct 15, 2018 |
$24
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Aug 16, 2018 |
$22
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Aug 16, 2018 |
$22
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Aug 16, 2018 |
$19
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Jan 10, 2018 |
$13
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Jul 3, 2018 |
$13
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Jul 12, 2018 |
$13
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jul 3, 2018 |
$13
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jul 3, 2018 |
$13
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jul 12, 2018 |
$13
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Oct 10, 2018 |
$12
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Dec 15, 2018 |
$12
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Dec 15, 2018 |
$12
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Sep 15, 2018 |
$11
|
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
MORPHINE SULPHATE
TRAMADOL HYDROCHLORIDE
TRAMADOL AND ACETAMINOPHEN
|
Consulting
|
PAR PHARMACEUTICAL, INC. |
|
Oct 15, 2018 |
$10
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jul 11, 2018 |
$10
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Jul 3, 2018 |
$10
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Jul 3, 2018 |
$9
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Jul 25, 2018 |
$6
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jul 3, 2018 |
$6
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Jul 3, 2018 |
$6
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Jul 12, 2018 |
$6
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Jul 12, 2018 |
$6
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Sep 15, 2018 |
$6
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Sep 15, 2018 |
$5
|
FENTANYL
|
Promotional Speaking/Other
|
MYLAN INC. |
|
Sep 15, 2018 |
$5
|
No Listed Product
|
Grant
|
PURDUE PHARMA L.P. |
|
Oct 15, 2018 |
$5
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Sep 15, 2018 |
$4
|
MORPHINE SULFATE ER TABLETS
OXYCODONE HYDROCHLORIDE ER TABLET
OXYMORPHONE HYDROCHLORIDE ER TABLET
|
Consulting
|
WEST-WARD PHARMACEUTICALS |
|
Oct 10, 2018 |
$3
|
REPROCESSED EP CATHETERS
|
Promotional Speaking/Other
|
STRYKER CORPORATION |
|
Jul 3, 2018 |
$3
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Jul 25, 2018 |
$3
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Sep 15, 2018 |
$3
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Jul 12, 2018 |
$2
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Oct 15, 2018 |
$2
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jul 12, 2018 |
$2
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Dec 15, 2018 |
$1
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Dec 15, 2018 |
$1
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Oct 15, 2018 |
$1
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Aug 16, 2018 |
$1
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Jul 25, 2018 |
$1
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Oct 15, 2018 |
$1
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Sep 15, 2018 |
$0
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Aug 16, 2018 |
$0
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Sep 15, 2018 |
$0
|
OPANA
OPANA ER
|
Consulting
|
ENDO PHARMACEUTICALS INC. |
|
Oct 15, 2018 |
$0
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Aug 16, 2018 |
$0
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|
Sep 15, 2018 |
$0
|
MORPHINE SULFATE EXTENDED RELEASE CAPSULES USP CII
|
Consulting
|
UPSHER-SMITH LABORATORIES LLC |
|
Sep 15, 2018 |
$0
|
ZOHYDRO ER
|
Consulting
|
PERNIX THERAPEUTICS HOLDINGS, INC. |
|